The Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis, Leslie B. Gordon, Francis S. Collins, Thomas Glover, Michael W. Glynn, Brian C. Capell, Adrienne D. Cox; and Channing J. Der, Patent Number 7,838,531, November 23, 2010
Peptides binding SH3 domain of cortatin and their use, Brian K. Kay, Andrew B. Sparks, Judith M. Thorn, Lawrence A. Quilliam, Channing J. Der, Dana M. Fowlkes, and James E. Rider, European Patent Number 897392, November 17, 2004
Src SH3 binding peptides and methods of isolating and using same, Brian K. Kay, Andrew B. Sparks, Judith M. Thorn, Lawrence A. Quilliam, and Channing J. Der; U.S. Patent Number 6,703,482, March 9, 2004
Nck SH3 binding peptides, Andrew B. Sparks, Brian K. Kay, Judith M. Thorn; Lawrence A. Quilliam; Channing J. Der, Dana M. Fowlkes, and James E. Rider; Patent Number 6,432,920, August 13, 2002
Src SH3 binding peptides and methods of isolating and using same, Brian K. Kay, Andrew B. Sparks, Lawrence A. Quilliam, and Channing J. Der; U.S. Patent Number 6,303,574, October 16, 2001
Grb2 SH3 binding peptides and methods of isolating and using same, Andrew B. Sparks, Brian K. Kay, Judith M. Thorn; Lawrence A. Quilliam; Channing J. Der, Dana M. Fowlkes, and James E. Rider; U.S. Patent Number 6,184,205, February 6, 2001
Shc proteins, Channing J. Der, John P. O’Bryan, and Anthony Pawson, U.S. Patent Number 6,077,686, June 20, 2000
